{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T19:55:29Z","timestamp":1740167729583,"version":"3.37.3"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2023,10,20]],"date-time":"2023-10-20T00:00:00Z","timestamp":1697760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,10,20]],"date-time":"2023-10-20T00:00:00Z","timestamp":1697760000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP16cm0106301","JP17cm0106301","JP18cm0106301","JP19cm0106301","JP20cm0106301","JP21cm0106301","20ae0101074h0001","21ae0101074h0001","22ae0101074h0001"],"award-info":[{"award-number":["JP16cm0106301","JP17cm0106301","JP18cm0106301","JP19cm0106301","JP20cm0106301","JP21cm0106301","20ae0101074h0001","21ae0101074h0001","22ae0101074h0001"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"MEXT | Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["21K19900","22H02918"],"award-info":[{"award-number":["21K19900","22H02918"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Leukemia"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1038\/s41375-023-02059-9","type":"journal-article","created":{"date-parts":[[2023,10,20]],"date-time":"2023-10-20T18:02:23Z","timestamp":1697824943000},"page":"2502-2506","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Clinical landscape of TP73 structural variants in ATL patients"],"prefix":"10.1038","volume":"37","author":[{"given":"Hiroaki","family":"Hiramatsu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rui","family":"Yokomori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liu","family":"Shengyi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2724-8009","authenticated-orcid":false,"given":"Norio","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seiichi","family":"Mori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9236-9061","authenticated-orcid":false,"given":"Kazuma","family":"Kiyotani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9363-4584","authenticated-orcid":false,"given":"Osamu","family":"Gotoh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shigeru","family":"Kusumoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9826-7616","authenticated-orcid":false,"given":"Nobuaki","family":"Nakano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Youko","family":"Suehiro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Asahi","family":"Ito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ilseung","family":"Choi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eiichi","family":"Ohtsuka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michihiro","family":"Hidaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kisato","family":"Nosaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5935-0385","authenticated-orcid":false,"given":"Makoto","family":"Yoshimitsu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshitaka","family":"Imaizumi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinsuke","family":"Iida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8843-406X","authenticated-orcid":false,"given":"Atae","family":"Utsunomiya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tetsuo","family":"Noda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6563-9807","authenticated-orcid":false,"given":"Hiroyoshi","family":"Nishikawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryuzo","family":"Ueda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1621-4954","authenticated-orcid":false,"given":"Takaomi","family":"Sanda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1060-0777","authenticated-orcid":false,"given":"Takashi","family":"Ishida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,10,20]]},"reference":[{"key":"2059_CR1","doi-asserted-by":"publisher","first-page":"2326","DOI":"10.1182\/blood-2017-06-792184","volume":"130","author":"RWJ Wong","year":"2017","unstructured":"Wong RWJ, Ngoc PCT, Leong WZ, Yam AWY, Zhang T, Asamitsu K, et al. Enhancer profiling identifies critical cancer genes and characterizes cell identity in adult T-cell leukemia. Blood. 2017;130:2326\u201338.","journal-title":"Blood."},{"key":"2059_CR2","doi-asserted-by":"publisher","first-page":"2293","DOI":"10.1038\/s41375-022-01655-5","volume":"36","author":"JZL Ong","year":"2022","unstructured":"Ong JZL, Yokomori R, Wong RWJ, Tan TK, Ueda R, Ishida T, et al. Requirement for TP73 and genetic alterations originating from its intragenic super-enhancer in adult T-cell leukemia. Leukemia. 2022;36:2293\u2013305.","journal-title":"Leukemia."},{"key":"2059_CR3","doi-asserted-by":"publisher","first-page":"1520","DOI":"10.1158\/1078-0432.CCR-09-2697","volume":"16","author":"T Ishii","year":"2010","unstructured":"Ishii T, Ishida T, Utsunomiya A, Inagaki A, Yano H, Komatsu H, et al. Defucosylated humanized anti-CCR4 monoclonal antibody KW-0761 as a novel immunotherapeutic agent for adult T-cell leukemia\/lymphoma. Clin Cancer Res. 2010;16:1520\u201331.","journal-title":"Clin Cancer Res"},{"key":"2059_CR4","doi-asserted-by":"publisher","first-page":"2418","DOI":"10.3324\/haematol.2021.280352","volume":"107","author":"N Tanaka","year":"2022","unstructured":"Tanaka N, Mori S, Kiyotani K, Ota Y, Gotoh O, Kusumoto S, et al. Genomic determinants impacting the clinical outcome of mogamulizumab treatment for adult T-cell leukemia\/lymphoma. Haematologica. 2022;107:2418\u201331.","journal-title":"Haematologica."},{"key":"2059_CR5","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1093\/bioinformatics\/btr670","volume":"28","author":"V Boeva","year":"2012","unstructured":"Boeva V, Popova T, Bleakley K, Chiche P, Cappo J, Schleiermacher G, et al. Control-FREEC: a tool for assessing copy number and allelic content using next-generation sequencing data. Bioinformatics. 2012;28:423\u20135.","journal-title":"Bioinformatics."},{"key":"2059_CR6","doi-asserted-by":"publisher","DOI":"10.1186\/s12859-018-2409-6","volume":"19","author":"Y Kang","year":"2018","unstructured":"Kang Y, Nam SH, Park KS, Kim Y, Kim JW, Lee E, et al. DeviCNV: detection and visualization of exon-level copy number variants in targeted next-generation sequencing data. BMC Bioinform. 2018;19:381.","journal-title":"BMC Bioinform"},{"key":"2059_CR7","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1111\/j.1365-2141.1991.tb08051.x","volume":"79","author":"M Shimoyama","year":"1991","unstructured":"Shimoyama M. Diagnostic criteria and classification of clinical subtypes of adult T-cell leukemia-lymphoma. A report from the Lymphoma Study Group (1984\u20131987). Br J Haematol. 1991;79:428\u201337.","journal-title":"Br J Haematol"},{"key":"2059_CR8","doi-asserted-by":"publisher","first-page":"8064","DOI":"10.1080\/21655979.2022.2051853","volume":"13","author":"H Ren","year":"2022","unstructured":"Ren H, Yang B, Li M, Lu C, Li X. RAB26 contributes to the progression of non-small cell lung cancer after being transcriptionally activated by SMAD3. Bioengineered. 2022;13:8064\u201375.","journal-title":"Bioengineered"},{"key":"2059_CR9","doi-asserted-by":"publisher","first-page":"103811","DOI":"10.1016\/j.isci.2022.103811","volume":"25","author":"A Uboveja","year":"2022","unstructured":"Uboveja A, Satija YK, Siraj F, Saluja D. p73-regulated FER1L4 lncRNA sponges the oncogenic potential of miR-1273g-3p and aids in the suppression of colorectal cancer metastasis. iScience. 2022;25:103811.","journal-title":"iScience"},{"key":"2059_CR10","doi-asserted-by":"publisher","first-page":"4593","DOI":"10.1111\/cas.15120","volume":"112","author":"H Li","year":"2021","unstructured":"Li H, Zhou Y, Wang M, Wang H, Zhang Y, Peng R, et al. DOC-2\/DAB2 interactive protein destabilizes c-Myc to impair the growth and self-renewal of colon tumor-repopulating cells. Cancer Sci. 2021;112:4593\u2013603.","journal-title":"Cancer Sci"},{"key":"2059_CR11","doi-asserted-by":"publisher","first-page":"217","DOI":"10.3389\/fcell.2020.00217","volume":"8","author":"C Casalou","year":"2020","unstructured":"Casalou C, Ferreira A, Barral DC. The role of ARF family proteins and their regulators and effectors in cancer progression: a therapeutic perspective. Front Cell Dev Biol. 2020;8:217.","journal-title":"Front Cell Dev Biol"},{"key":"2059_CR12","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-023-05590-w","volume":"14","author":"B Liu","year":"2023","unstructured":"Liu B, Yao X, Zhang C, Liu Y, Wei L, Huang Q, et al. PTK6 inhibits autophagy to promote uveal melanoma tumorigenesis by binding to SOCS3 and regulating mTOR phosphorylation. Cell Death Dis. 2023;14:55.","journal-title":"Cell Death Dis"},{"key":"2059_CR13","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-020-2258-x","volume":"11","author":"N Kazim","year":"2020","unstructured":"Kazim N, Adhikari A, Oh TJ, Davie J. The transcription elongation factor TCEA3 induces apoptosis in rhabdomyosarcoma. Cell Death Dis. 2020;11:67.","journal-title":"Cell Death Dis"},{"key":"2059_CR14","first-page":"9516808","volume":"2022","author":"D Liu","year":"2022","unstructured":"Liu D, Wang X, Liu Y, Li C, Zhang Z, Lv P. Actin-binding LIM 1 (ABLIM1) inhibits glioblastoma progression and serves as a novel prognostic biomarker. Dis Mark. 2022;2022:9516808.","journal-title":"Dis Mark"},{"key":"2059_CR15","doi-asserted-by":"publisher","first-page":"3727","DOI":"10.1074\/jbc.M112.417568","volume":"288","author":"DT Johnson","year":"2013","unstructured":"Johnson DT, Luong R, Lee SH, Peng Y, Shaltouki A, Lee JT, et al. Deletion of leucine zipper tumor suppressor 2 (Lzts2) increases susceptibility to tumor development. J Biol Chem. 2013;288:3727\u201338.","journal-title":"J Biol Chem"}],"container-title":["Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41375-023-02059-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41375-023-02059-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41375-023-02059-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,27]],"date-time":"2023-11-27T08:07:07Z","timestamp":1701072427000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41375-023-02059-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,20]]},"references-count":15,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2023,12]]}},"alternative-id":["2059"],"URL":"https:\/\/doi.org\/10.1038\/s41375-023-02059-9","relation":{},"ISSN":["0887-6924","1476-5551"],"issn-type":[{"type":"print","value":"0887-6924"},{"type":"electronic","value":"1476-5551"}],"subject":[],"published":{"date-parts":[[2023,10,20]]},"assertion":[{"value":"11 January 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 September 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 October 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 October 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"SK received research funding from Chugai, Daiichi-Sankyo, and honoraria from Chugai, Kyowa Kirin. NN received honoraria from Novartis, Takeda, Chugai, Celgene, Otsuka, Nippon Shinyaku, Kyowa Kirin, Asahi-Kasei, and consulting fees from JIMRO. YS received research funding from Chugai, Novartis, Bayer, Eisai, Ono, Otsuka, Pfizer, Amgen, Daiichi Sankyo, Celgene, and Incyte. MH received honoraria from Chugai, and consulting fees from Symbio. KN received research funding from Chugai, Kyowa Kirin, and honoraria from Meiji Seika, Celgene, Eisai, Novartis and had a Consultant or advisory role from Kyowa Kirin. MY received honoraria from Novartis, Takeda, and consulting fees from Takeda. YI received honoraria from Bristol-Myers, Celgene, CHUGAI, Eisai, Kyowa Kirin, Meiji Seika, Nippon Shinyaku, Sanofi, SymBio, Sumitomo Dainippon. SI received honoraria and research grants from Janssen, Sanofi, Takeda, Ono, Celgene, Bristol-Myers Squibb, and Daiichi-Sankyo, also received research grants from Novartis, Pfizer, Amgen, Caelum, Abbvie, Glaxo-Smithklein, Chugai and Kyowa Kirin. Atae Utsunomiya received honoraria from Kyowa Kirin, Daiichi-Sankyo, Bristol-Myers, and consulting fees from HUYA Japan, JIMRO, Meiji Seika and Otsuka Medical Devices. HN received research funding and honoraria from Ono, Bristol-Myers, MSD, Chugai, and research funding from Taiho, Daiichi-Sankyo, Kyowa Kirin, Zenyaku, Oncolys BioPharma, Debiopharma, Asahi-Kasei, Sysmex, Fujifilm, SRL, Astellas, Sumitomo Dainippon and BD Japan outside of this study. RU received research funding from Kyowa Kirin, Chugai Pharmaceutical, and Ono. The other authors have no COI to disclose.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}